Vantage Consulting Group’s Halozyme HALO Stock Holding History

Vantage Consulting Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-429	Closed	-$18K	–	716
2020 Q4	$18K	Buy	+429	New	+$15.4K	﹤0.01%	918

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vantage Consulting Group's HALO Position: Q1 2021 in Review

Vantage Consulting Group sold out of Halozyme (HALO) in Q1 2021, closing a stake of 429 shares — an estimated $18K sold.

Vantage Consulting Group first reported a position in HALO in Q4 2020 and held it in 1 quarter. The position peaked at $18K in Q4 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

Vantage Consulting Group reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 429 Halozyme shares in Q1 2021, an estimated $18K.
Vantage Consulting Group first reported a position in Halozyme in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Halozyme position peaked at $18K in Q4 2020.
336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.